EPISODE · Feb 5, 2025 · 1 MIN
Amgen Inc. (AMGN), 2024 Q4 earnings digest
from Earnings Report Digest · host ValueVerge
$AMGN has released its Q4 2024 earnings, featuring an EPS of $5.31, surpassing expectations by $0.23, and revenues of $9.09B, up 10.86% YoY. The company recorded robust product sales growth of 19% for the full year and sustained momentum across key medications like Repatha and EVENITY, with significant unmet patient needs driving future potential.
Embed this episode
NOW PLAYING
Amgen Inc. (AMGN), 2024 Q4 earnings digest
0:00
1:54
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Earnings Report Digest?
This episode is 1 minute long.
When was this Earnings Report Digest episode published?
This episode was published on February 5, 2025.
Can I download this Earnings Report Digest episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!